For luminal B, HER2 enriched and triple-negative breast cancer, TCNP patients had decreased DFS, OS and BCSS as compared to TBPQ patients (all p < 0.05) (Figures 4D–L). Here, ERBB2 is linked to triple-negative breast carcinoma.